Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gliosarcoma × poly ICLC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 18 Glioblastoma 10 Pancreatic Neoplasms 9 Neoplasms 9 Breast Neoplasms 8 Ovarian Neoplasms 7 Glioma 7 Carcinoma, Non-Small-Cell Lung 6 Colonic Neoplasms 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Prostatic Neoplasms 4 Fallopian Tube Neoplasms 4 Astrocytoma 4 Oligodendroglioma 3 Neoplasms, Plasma Cell 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Merkel Cell 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Skin Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2

Interventions

Temozolomide 119 Radiotherapy 80 Bevacizumab 39 Radiation 30 Carmustine 25 Irinotecan 20 Magnetic Resonance Spectroscopy 19 Erlotinib Hydrochloride 19 Chemotherapy, Adjuvant 17 Surgical Procedures, Operative 13 Carboplatin 13 sargramostim 12 O(6)-benzylguanine 12 Radiotherapy, Intensity-Modulated 10 Radiotherapy, Conformal 10 Thalidomide 8 Imatinib Mesylate 8 Drug Therapy 8 Radiosurgery 7 Procarbazine 7 Gene Expression Profiling 7 pembrolizumab 6 motexafin gadolinium 6 cediranib 6 Vorinostat 6 Lomustine 6 Immunohistochemistry 6 Gefitinib 6 Filgrastim 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00052715 2018-07-18

Poly-ICLC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

31 enrolled 8 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡